THE FIRST PRODUCT IS SHIPPING. With the full rebrand of Researgency.ai now complete, the platform is live and ready for enterprise clients. Kala’s scientists, working alongside Younet’s AI engineering ...
The nation that leads in AI-bio will shape global standards, industrial supply chains, medical innovation, climate resilience ...
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. The head biotech analyst at Goldman Sachs, Salveen Richter, made an appearance on CNBC’s “Squawk Box” on ...
For decades, women’s health has struggled with gaps in research and a lack of tools designed specifically for female biology. Hormone testing, in particular, has often left women with raw numbers and ...
Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype. To get it in your inbox, sign up here ...
AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...
The expanded team brings decades of experience spanning biotechnology, AI, and commercialization–advancing Salt AI’s mission to help translational scientists and drug developers accelerate discovery ...
Recursion Pharmaceuticals crashed 90% but JPMorgan upgraded with $11 target implying near tripling. Eli Lilly partnered with Nvidia on a $1B AI drug discovery collaboration using Vera Rubin chips.
RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Are you ahead, or behind on retirement? SmartAsset's free ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results